Vaccine-induced protection from homologous tier 2 SHIV challenge in nonhuman primates depends on serum neutralizing antibody titers.

/in
Pauthner MG, Nkolola JP, Havenar-Daughton C, Murrell B, Reiss SM, Bastidas R, Prévost J, Nedellec R, von Bredow B, Abbink P, Cottrell CA, Kulp DW, Tokatlian T, Nogal B, Bianchi M, Li H, Lee JH, Butera ST, Evans DT, Hangartner L, Finzi A, Wilson IA, Wyatt RT, Irvine DJ, Schief WR, Ward AB, Sanders RW, Crotty S, Shaw GM, Barouch DH*, Burton DR*. Vaccine-induced protection from homologous tier 2 SHIV challenge in nonhuman primates depends on serum neutralizing antibody titers. Immunity 2019; 50:241-252. [Article]